findmyKOL
Clinical trialNCT07143019RecruitingInterventional

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

Sponsorphenox Inc.Enrollment214Aneurysm, IntracranialBrain AneurysmFusiform AneurysmHemorrhagic StrokeSaccular Aneurysm
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

    Andrew Ducruet, MD
    Recruiting
  • Ucsf Medical Center

    San Francisco, California, United States

    Daniel M S Raper, MBBS
    Recruiting
  • University of Colorado Anschutz

    Aurora, Colorado, United States

    Joshua Seinfeld, MD
    Recruiting
  • Swedish Medical Research Center

    Englewood, Colorado, United States

    Don Frei, MD
    Recruiting
  • Baptist Health Research Institute

    Jacksonville, Florida, United States

    Eric Sauvageau, MD
    Recruiting
  • Piedmont Atlanta Hospital

    Atlanta, Georgia, United States

    Michael F Stiefel, MD, PhD
    Recruiting
  • Northwestern Medicine

    Chicago, Illinois, United States

    Matthew B Potts, MD
    Recruiting
  • Advocate Lutheran General Hospital

    Park Ridge, Illinois, United States

    Krishna Joshi, MD
    Recruiting
  • University of Iowa

    Iowa City, Iowa, United States

    Kathleen Dlouhy, MD, MBA, MA
    Recruiting
  • Tufts Medical Center

    Boston, Massachusetts, United States

    Adel Malek, MD
    Recruiting
  • Washu Medicine

    St Louis, Missouri, United States

    Joshua W Osbun, MD, FACS, FAHA
    Recruiting
  • Ubns

    Buffalo, New York, United States

    Adnan Siddiqui, MD, PhD, FAHA
    Recruiting
  • North Shore University Hospital - Northwell Health

    Manhasset, New York, United States

    Athos Patsalides, MD
    Recruiting
  • Nyu Langone Health

    New York, New York, United States

    Eytan Raz, MD, PhD
    Recruiting
  • Newyork-Presbyterian / Weill Cornell Medical Center

    New York, New York, United States

    Jared Knopman, MD
    Recruiting
  • Stony Brook University Hospital

    Stony Brook, New York, United States

    David Fiorella, MD
    Recruiting
  • East Carolina University Health Medical Center

    Greenville, North Carolina, United States

    Richard T Dalyai, MD
    Recruiting
  • the University of Oklahoma

    Oklahoma City, Oklahoma, United States

    Hakeem Shakir, MD
    Recruiting
  • Oregon Health & Science University Hospital (ohsu) / Oregon Stroke Center

    Portland, Oregon, United States

    Ryan A Priest, MD
    Recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Jan-Karl Burkhardt, MD
    Recruiting
  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

    Rohan Chitale, MD
    Recruiting
  • University of Washington - Harborview Medical Center

    Seattle, Washington, United States

    Michael Levitt, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Mar 2026
Primary completion
31 Jul 2027
Completion
31 Jul 2032
Last update posted
10 Aug 2026
Registered enrollment
214
Registry id
NCT07143019

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.